Tecogen Inc.
AMEX:TGENElectrical Equipment & Parts
+$0.24 today
- Market cap
- $53.43M
- Beta
- 2.09
- P/E (TTM)
- -18.5
- EPS (TTM)
- -$0.33
Volume 0.08M
Average 0.56M
TGEN Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Tecogen Inc.AMEX: TGEN
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development grows in line with its trailing trend
Q1 FY2026 research & development of $363.82K rose 24.3% year over year, in line with the +23.8% change in trailing-twelve-month research & development. Sequentially, it rose 18.3% from the prior quarter. Over 3 fiscal years it compounded at +16.8% a year.
Context
- Research & development amounted to 4.3% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +24.3% holds above the trailing-twelve-month pace of +23.8%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 1.17M USD
- Year-over-year change
- +21.3%
- 4-year CAGR
- +21.1%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.17M | +21.3% |
| FY2024 | 2024-12-31 | 961.84K | +14.5% |
| FY2023 | 2023-12-31 | 840.01K | +14.6% |
| FY2022 | 2022-12-31 | 732.87K | +35.2% |
| FY2021 | 2021-12-31 | 542.08K | — |
Research & Development vs competitors
How TGEN compares with its peers on the latest reported figures
- TGEN's LTM Mar 2026 research & development of $1.24M is the 3rd highest of the 11 companies compared; the peer median is $0.
- Its year-over-year change of +23.8% is the 2nd highest of 5, against a peer median of -24.8%.
- Research & development amounts to 4.7% of revenue for TGEN, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $71.24M | -3.1% | +23.4% | 378.9% | |
| LTM Mar 2026 | $5.01M | +43.6% | +8.4% | 7.1% | |
| LTM Mar 2026 | $1.24M | +23.8% | +16.8% | 4.7% | |
| LTM Mar 2026 | $836.14K | -46.5% | -16.6% | — | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
BNCCEA Industries Inc. Common Stock | LTM Apr 2026 | $0 | — | — | 0.0% |
| Peer median (excluding TGEN) | $0 | -24.8% | +8.4% | 0.0% | |
Competitors are the stored peer set for TGEN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 24.4M | 25M | 25.14M | 22.62M | 27.07M |
| Cost of Revenue | 12.81M | 13.94M | 14.94M | 12.75M | 17.25M |
| Gross Profit | 11.59M | 11.07M | 10.2M | 9.87M | 9.82M |
| Gross Margin | 47.5% | 44.3% | 40.6% | 43.6% | 36.3% |
| Research & Development | 542.08K | 732.87K | 840.01K | 961.84K | 1.17M |
| Selling, General & Admin | 12.27M | 12.72M | 13.81M | 13.24M | 15.79M |
| Operating Expenses | 12.81M | 13.42M | 14.62M | 14.4M | 16.96M |
| Depreciation & Amortization | 469.85K | 428.35K | 567.71K | 553.78K | 877.68K |
| EBITDA | 4.27M | (1.9M) | (3.88M) | (3.78M) | (7.2M) |
| EBITDA Margin | 17.5% | -7.6% | -15.4% | -16.7% | -26.6% |
| Operating Income | (1.22M) | (2.35M) | (4.41M) | (4.53M) | (7.13M) |
| Operating Margin | -5.0% | -9.4% | -17.6% | -20.0% | -26.3% |
| Interest Income | 0 | 0 | 0 | 0 | 151.71K |
| Interest Expense | 37.98K | 16.25K | 77.05K | 117.12K | 150.29K |
| Other Income / Expenses | 4.98M | (32.22K) | (77.05K) | (117.12K) | (1.1M) |
| Income Before Tax | 3.76M | (2.38M) | (4.49M) | (4.65M) | (8.23M) |
| Pre-Tax Margin | 15.4% | -9.5% | -17.9% | -20.6% | -30.4% |
| Income Tax Expense | 19.49K | 16.35K | 32.49K | 22.57K | 20.62K |
| Net Income | 3.7M | (2.45M) | (4.6M) | (4.76M) | (8.25M) |
| Net Margin | 15.1% | -9.8% | -18.3% | -21.0% | -30.5% |
| EPS (Basic) | 0.15 | (0.10) | (0.18) | (0.19) | (0.30) |
| EPS (Diluted) | 0.15 | (0.10) | (0.18) | (0.19) | (0.30) |
| Weighted Avg Shares | 24.85M | 24.85M | 24.85M | 24.85M | 27.23M |
| Weighted Avg Shares (Diluted) | 25.12M | 24.85M | 24.85M | 24.86M | 27.23M |
Tecogen Inc.
AMEX:TGEN
Intrinsic Alpha fair value
Locked
Current Price
$1.77
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.